期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 144, 期 4, 页码 204-211出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2020.09.001
关键词
Antisense oligonucleotide; Macrophage cell; Righting reflex; ROS production; SMA model mouse
The deficiency of survival motor neuron (SMN) protein can result in the onset of spinal muscular atrophy (SMA), an autosomal recessive disorder characterized by a progressive loss of motor neurons and skeletal muscle atrophy. The mechanism underlying SMA pathology remains unclear. Here, we demonstrate that SMN protein regulates oxidative stress and inflammatory response in microglia. Antisense oligonucleotide, which increases SMN protein expression (SMN-ASO), attenuated SMA model mice phenotypes and suppressed the activation of microglia in the spinal cord. The expression of oxidative stressmarker in microglia was decreased by SMN-ASO injection in SMA model mice. Increased reactive oxygen species production and subsequent antioxidative stress reaction was observed in SMN protein-depleted RAW264.7. Furthermore, nuclear factor kappa B (NF kappa B) and c-Jun amino terminal kinase (JNK) signaling, whichmainlymediate the inflammatory response, are activated in SMN protein-depleted RAW264.7. Tumor necrosis factor-alpha (TNF-alpha) production is also increased in SMN protein-depleted RAW264.7. These findings suggest that SMN protein regulates oxidative stress and inflammatory response in microglia, supporting current claims that microglia can be an effective target for SMA therapy. (C) 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据